QYResearch: In the last several years, Philippines market of Veterinary Vaccine developed steadily, with an average growth rate of 9.3% Custom Research｜Research Report｜Management Consulting｜Seminar｜Database www.qyresearch.com
QYResearch Beijing Hengzhou Bozhi International Information Consulting
Web: qyresearchglobal.com | qyresearcheurope.com | qyresearch.com | qyresearch.com/english | qyresearchjapan.com TEL:+86-13660489419, Office:+86-2086655165 Media: press@qyresearch.com Marketing: sales@qyresearch.com Facebook: @QYResearchOfficial Twitter: @QYResearch_ Wechat Official Account: QYResearch, Weibo: 恒州博智 www.qyresearch.com
QYResearch Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether.
www.qyresearch.com
QYResearch In the last several years, Philippines market of Veterinary Vaccine developed steadily, with an average growth rate of 9.3%. In 2016, Philippines sales of Veterinary Vaccine are nearly 60 million USD; the actual production is about 1900 million doses. The Philippines average price of Veterinary Vaccine is in the decreasing trend, from 29.3 USD/K Doses in 2011 to 28 USD/ K Doses in 2016. With the situation of Philippines economy, prices will be in decreasing trend in the following five years. Merck is the largest supplier of Veterinary Vaccine, with a sales market share nearly 20.8% in 2016. Following Merck, Merial is the second supplier of Veterinary Vaccine, with a sales market share nearly 19.7% in 2016
www.qyresearch.com
QYResearch There are four kinds of Veterinary Vaccine, which are Live Attenuated Vaccines, Inactivated Vaccines, DNA Vaccines, and others; Live attenuated vaccines hold the largest share of the veterinary vaccines market, with a sales market share nearly 55.2% in 2016, the live attenuated vaccines segment is mainly driven by factors such as the increasing prevalence of diseases among porcine and poultry animals as well as the ease of administration and long-term immunity offered by these vaccines.
www.qyresearch.com
QYResearch Market competition is intense. Merck, Merial, Boehringer Ingelheim, Zoetis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
More: http://www.qyresearchglobal.com/goods-676056.html www.qyresearch.com